The quantitative AMH hormone detection kit is a precise tool for measuring AMH concentration in serum or plasma. This highly sensitive kit is designed for evaluating fertility and ovarian reserves, diagnosing premature ovarian insufficiency, polycystic ovary syndrome, and assessing the effectiveness of infertility treatments. It is also used for monitoring conditions related to reduced follicular reserves and planning fertility treatments. Measuring AMH with this kit helps predict success in assisted reproductive treatments and select the best treatment method. This kit significantly aids physicians in more accurate diagnosis of fertility disorders and better patient management.
The quantitative AMH hormone detection kit is an advanced diagnostic tool designed for the quantitative measurement of Anti-Müllerian Hormone (AMH) in human serum or plasma using the ELISA method. This kit, with high accuracy and sensitivity, is used for evaluating reproductive health and ovarian reserves in women, and for assessing the function of reproductive organs.
AMH is secreted by growing ovarian follicles and is a suitable indicator for assessing the number and quality of oocytes. Unlike FSH and estradiol, AMH levels are constant throughout the menstrual cycle and can be measured at any time. This hormone is not affected by gonadotropins and solely reflects follicular reserve. AMH measurement is particularly useful in women at risk of reduced ovarian reserve, such as those with Polycystic Ovary Syndrome, a family history of premature menopause, severe endometriosis, or chemotherapy treatments.
Applications of the Quantitative AMH Hormone Detection Kit
The AMH kit is used for evaluating fertility, diagnosing premature ovarian failure, polycystic ovary syndrome, and assessing the effectiveness of fertility treatments. It is also used to evaluate follicular reserves and investigate clinical conditions related to reduced ovarian reserves.
How to Use the Quantitative AMH Hormone Detection Kit
Expected Values
Due to biological differences between various populations, as well as factors such as age, gender, race, and geographical factors, it is recommended that each laboratory establish its own normal reference range:
Age Group | Mean (ng/mL) | 5th to 95th Percentile (ng/mL)
—|—|—
Males >12 yrs | 5.7 | 0.7 – 19
Boys 24 months to 12 yrs | 60 | 7.4 – 243
Women 13 to 25 yrs | 4.9 | 0.85 – 13.0
Women 26 to 30 yrs | 4.07 | 0.1 – 8.5
Women 31 to 35 yrs | 3.12 | 0.1 – 7.0
Women 36 to 40 yrs | 1.81 | 0.09 – 6.1
Women 41 to 45 yrs | 0.72 | 0.05 – 3.9
Girls 24 months to 12 yrs | 1.3 | < 8.9
Girls under 24 months | – | < 4.7
Women with reduced ovarian reserve | – | < 1.0
Menopausal women | – | < 0.5
| AMH Level (ng/mL) | Interpretation |
| Less than 0.36 | Low ovarian reserve (POF) |
| 0.36 – 0.69 | Borderline low ovarian reserve |
| 0.69 – 3.8 | Normal range for ovarian reserve |
| 3.8 – 8.9 | High ovarian reserve |
Sensitivity:
The minimum measurable concentration of AMH that can be distinguished from a sample without analyte is called sensitivity. This value, calculated based on the mean concentration of the zero standard plus two times the standard deviation (obtained from 10 tests), is 0.03 ng/ml.
